Here's why the Immuron (ASX:IMC) share price is rocketing 31% today
The Immuron Ltd (ASX: IMC) share price is shooting out the lights on Wednesday following a positive update from the company.
Stay updated with breaking news from Immuron Ltd. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
The Immuron Ltd (ASX: IMC) share price is shooting out the lights on Wednesday following a positive update from the company.
Major Players: 95+ Key Companies Prominent Players: 89bio Inc, ABIONYX Pharma SA, Abivax SA, Abliva AB, Acquist Therapeutics, AdAlta Ltd, Afimmune Biopharma Ltd, Akero Therapeutics Inc, Albireo Pharma Inc, Aldeyra Therapeutics Inc, Ascletis Pharma Inc, Zhejiang Doer Biologics Corp, Asdera LLC, Assembly Biosciences Inc, AstraZeneca Plc, Auransa Inc, Avaliv Therapeutics Inc, Avolynt Inc, ChemoCentryx Inc, ChemomAb Ltd, Dicerna Pharmaceuticals Inc, Dr. Falk Pharma GmbH, DURECT Corp, Eli Lilly and Co, Enanta Pharmaceuticals Inc EncuraGen Inc, Engitix Ltd, Hepion Pharmaceuticals Inc, Heprotech...
FinancialContent fully hosted finance channel